Study of Dapivirine Vaginal Ring (VR) in Adolescents

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

June 27, 2014

Primary Completion Date

July 5, 2016

Study Completion Date

June 8, 2018

Conditions
Human Immunodeficiency Virus
Interventions
COMBINATION_PRODUCT

placebo ring

intravaginal ring silicone elastomer intravaginal ring containing no drug product

COMBINATION_PRODUCT

dapivirine ring

intravaginal ring silicone elastomer intravaginal ring containing 25 mg dapivirine

Trial Locations (11)

10467

Montefiore Medical Center; 3514 Wayne Ave, The Bronx

15213

University of Pittsburgh CRS, 3601 fifth Ave, Room 737, Pittsburgh

University of Pittsburgh CRS, 3601 Fifth Avenue, Room 737; Falk Medical Building,, Pittsburgh

38105

St. Jude Children's Research Hospital 262 Danny Thomas PL., Memphis

St. Jude Children's Research Hospital; 262 Danny Thomas Pl., Memphis

80045

The university of Colorado, 13123 E. 16th Ave., Box 025, Aurora

The University of Colorado; 13123 E. 16th Ave., Box 025, Aurora

104467

Montefiore Medical Center, 3514 Wayne Ave, The Bronx

35294-2170

Alabama CRS 84519th street south, BBRB 203A, Birmingham

02215

The Fenway Institute, 1340 Boylston Street, Boston

The Fenway Institute; 1340 Boylston Street, Boston

Sponsors
All Listed Sponsors
collaborator

Microbicide Trials Network

NETWORK

collaborator

National Institutes of Health (NIH)

NIH

lead

International Partnership for Microbicides, Inc.

INDUSTRY

NCT02028338 - Study of Dapivirine Vaginal Ring (VR) in Adolescents | Biotech Hunter | Biotech Hunter